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PsoriasisAbstract Hijamah (a well-known Prophetic complimentary treatment) has been used for centuries
to treat various human diseases. It is considered that this traditional treatment (also known as wet
cupping) has the potential to treat many kinds of diseases. It is performed by creating a vacuum on
the skin by using a cup to collect the stagnant blood in that particular area. The vacuum at the end
is released by removing the cup. Superﬁcial skin scariﬁcation is then made to draw the blood stag-
nation out of the body. This technique needs to be performed in aseptic conditions by a well trained
Hijamah-physician. Prophet Muhammad (PBUH) had described Hijamah as the best treatment
humans can have. This novel treatment methodology has been successfully used as cure for numer-
ous diseases including skin diseases. In this case report, we discuss about the application of this
method in the treatment of psoriasis (an autoimmune skin disease). Results illustrated that with
Hijamah, disease can not only be controlled but can be brought to a nearly complete remission.
ª 2014 King Saud University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Background
Psoriasis is T-cell mediated autoimmune inﬂammatory skin
disease characterized by skin surface inﬂammation, epidermal
proliferation, hyperkeratosis, angiogenesis, and abnormal ker-
atinization (Rahman et al., 2012). At present, nearly 3% ofworld population is affected by this disease (Rahman et al.,
2012; Danielsen et al., 2013). It has genetic manifestations
and the risk of acquiring the disease is found in almost half
of the siblings if both parents had it. Risk drops to less than
a quarter if one of the parents had psoriasis (Psoriasis,
2014). Psoriasis is not limited to any particular area but can
range from a minor spot on the skin to the entire skin
(Psoriasis, 2014; Scho¨n and Boehncke, 2005).
T-Cell activated inﬂammatory response has been found to
be responsible as the main pathophysiology behind psoriasis
(Psoriasis and Law, 2011; Nickoloff et al., 1999). Once T-Cells
are activated, they migrate both from lymph nodes and
systemic circulation to the skin. These T cells further activate
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riasis (Nickoloff et al., 1999; Bonifati and Ameglio, 1999).
These cytokines include but not limited to TNF-a, IL-8, IL-
12 and macrophage inﬂammatory protein 3a (MIP-3a)
Danielsen et al., 2013; Psoriasis and Law, 2011; Biasi et al.,
1998. More notably, research for better disease understanding
and development of curable approach for psoriasis received
much attention in recent time as new studies showed that pso-
riasis is an important risk factor in many diseases. Lately, it
was found that psoriasis is an independent risk factor for dia-
betes (type 2 DM) and cardiovascular diseases, including
hypertension, and hypercholesterolemia (Wu et al., 2008;
Azfar et al., 2012). Moreover, other comorbidities commonly
associated with psoriasis are arthritis, depression, insomnia
and obstructive pulmonary disease (Wu et al., 2008). Available
therapies used for the management of psoriasis include topical
and systemic medications, phototherapy and combination of
both. Topical medications usually include Vitamin D, calcipot-
riol, corticosteroids (used systemically as well), dithranol and
retinoids. Systemic therapies include methotrexate, cyclospor-
ine and antibody therapy. Phototherapy includes radiation
therapy and Psoralen plus ultraviolet therapy. All these thera-
pies have potential limitations such as poor efﬁcacy, rapid
relapse of disease, drug and biological associated potential sideA 
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Figure 1 Images of patient’s limbs before Hijamah treatment: (A) Ri
(D) Left leg (near the knee).effects (for example; hepatotoxicity, nephrotoxicity, bone mar-
row suppression, organ toxicity and immunosuppression),
hyperlipidaemia, growth suppression, adrenal insufﬁciency,
Cushing’s syndrome, femoral head osteonecrosis, and possible
congenital malformations (Rahman et al., 2012; Menter et al.,
2009; Stanway, 2013; Australian Medicines Handbook, 2013).
Hijamah (wet cupping), is an effective treatment for many
diseases (Farhadi et al., 2009). Its efﬁcacy to treat the non spe-
ciﬁc lower back pain has already been established (Farhadi
et al., 2009). It was proven as a safe and better alternative ther-
apy to the usual allopathic medical care (AlBedah et al., 2011;
Ahmed et al., 2005). Some studies have found the effectiveness
of wet cupping combined with drug treatment superior to the
medical treatment alone (AlBedah et al., 2011). Beside this, wet
cupping therapy has also got the immune-modulatory effects
(Ahmed et al., 2005). Its ability to modulate the immune sys-
tem has well been established. It was thus postulated that this
aspect of Hijamah therapy can be used to treat other immune
related diseases as well.
2. Case history
Mr. Muhammad H. (MH) is a 30 year old male working and
living in Australia. He works as Incident Management AnalystB 
D 
ght leg (near the knee); (B) Lower left leg; (C) Lower right leg; and
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Figure 2 Images of Daivobet packing (A) and doctor prescription (B).
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Figure 3 Information regarding Daivobet on the web: (A). PBS scheme showing the cost of the cream, indication of use and the process
of obtaining the cream on PBS and (B) MIMS online drug information database.
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hobby. Three years ago, when he was helping to unload a car
engine from a truck, his right front leg scratched (a size less
than 5 cent coin), however, he was not worried at-all at that
time. After few weeks, he noticed that few bubble appeared
on the affected leg, which burst out and left a mark with slightitching. He went to the doctor and was prescribed steroid
cream. He started using the cream and the spots disappeared
gradually. But this was not the end of story. Spots/lesions kept
appearing and he kept using the cream, which not only cost
him high but also resulted in skin thinning followed by
easy bruising even with minimum shear. This made him really
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Figure 4 Images of patient’s limbs after Hijamah treatment showing the absence of psoriatic lesion except on elbow. (A) Right leg (near
the knee); (B) Left leg (near the knee); (C) Lower right leg; (D) Left lower leg; (E) Left elbow; and (F) Right elbow.
120 I.A. Malik et al.worried. Few days later, the lesions spread to the other leg,
arm, back and the head (Fig. 1A–D). He visited the doctor
and was again prescribed the high potency steroid combination
cream namely Daivobet (Fig. 2A and B). This combination is
used to treat psoriasis (Fig. 3A and B). The results were same
as before i.e. as long as the cream was being used, the lesion
would go away but as soon as the cream was stopped the prob-
lem would come back. He noticed that even during the regular
use of cream, the incidence of appearing of the new lesion was
unaffected, i.e. the steroid cream was not effective in prevent-
ing the new lesions. The situation was annoying and he ﬁnally
was referred to the skin specialist for further review. The spe-
cialist ordered the biopsy of the lesion and kept him on steroid
cream. The biopsy report came after few weeks and it failed to
ﬁnd any abnormality. This made him even more worried real-
izing that he is suffering from such a bad and progressive skin
condition and doctors failed to establish any deﬁnite diagnosis.
The plight was that according to doctors, there is no cure for
the disease and the condition could only be managed rather
slowed by the continuous use of steroid cream or other drugs.
Moreover there is no option to avoid the side effects of medical
therapy. Further, the cost of the cream was high i.e. 42.10
Australian dollars per four tube (Fig. 2A). Moreover this med-
icine is available through a complex prescribing procedure
(Fig. 3A). Later on, the patient visited his home country and
consulted a skin specialist, who conﬁrmed the disease as
psoriasis and advises him some other alternative drugs other
than steroids. But the problem was same: no complete remis-
sion and non tolerable side effects. Finally he contacted thequaliﬁed Hijamah therapist and was given advice not to worry
about it, as the Hijamah is an effective therapy for many dis-
eases including psoriasis, by the will of Allah. A Hadiths says
to the nearest meaning ‘‘indeed the best of treatments you have
is Hijamah’’ (Bukhari, xxxx).
3. Methodology, results and discussion
Mr. MH was counseled and was given advice to seek help of
ALLAH (the Creator) and the Hijamah therapy was started.
At this point the severity of the disease was examined using
the online tools like PASI (psoriasis area severity index) and
it was found to be 2. The wet cupping sessions (using the sterile
plastic cups to create a negative pressure on the skin and then
performing the superﬁcial skin incision to draw the stagnant
blood) were designed to be performed once a week on the basis
of diagnosis of the disease as psoriasis. He was advised to have
minimum seven sessions to completely get rid of the disease.
Hijamah was started and two days after the ﬁrst session,
lesions started to disappeared and reduced both in size and
number. The patient continued for further two sessions and
more than 90% of disease had gone. However, the patient
could not continue further sessions despite his willingness
due to his extreme business. It has been six months after the
last session and all his lesions disappeared completely
(Fig. 4A–D), and no itching is felt anywhere on the skin.
The patient has not used any other type of therapy after that.
Also no new lesion appeared anywhere except for some lesions
at below his elbow after 6 months (Fig 4E and F). One possible
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treatment as the patient received only three sessions instead of
initially advised schedule of seven sessions.
As this case report is not a conclusive evidence for the effec-
tiveness of Hijamah for the all types of psoriasis, yet reason-
ably demonstrates the efﬁcacy of Hijamah in treating
psoriasis. More research and trials are needed to fully elucidate
the effectiveness of Hijamah for all types of psoriasis with
varying degrees of severity.
4. Conclusion
Hijamah has been used for centuries to treat human diseases.
It is considered that this traditional treatment (also known
as wet cupping) has the potential to treat many kinds of dis-
eases. Its role in this regard has been greatly emphasized by
our prophet Muhammad (PHUH), not only verbally but prac-
tically as well. This case study puts some light on the effective-
ness of Hijamah to treat psoriasis.
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